Insogna Iris G, Ginsburg Elizabeth S
A reproductive endocrinology and infertility fellow at Brigham and Women's Hospital in Boston, Massachusetts.
A professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School and the medical director of the Assisted Reproductive Technologies Program at Brigham and Women's Hospital in Boston, Massachusetts; and a member of the ethics committee of the American Society for Reproductive Medicine.
AMA J Ethics. 2018 Dec 1;20(12):E1152-1159. doi: 10.1001/amajethics.2018.1152.
Disparities in access to infertility care and insurance coverage of infertility treatment represent marked injustices in US health care. The World Health Organization defines infertility as a disease. Infertility has multiple associated billing codes in use, as determined by the . However, the often-prohibitive costs associated with infertility treatment, coupled with the lack of universal insurance coverage mandates, contribute to health care inequity, particularly along racial and socioeconomic lines.
获得不孕不育治疗的机会差异以及不孕不育治疗的保险覆盖范围问题,体现了美国医疗保健领域存在的显著不公。世界卫生组织将不孕不育定义为一种疾病。根据[具体机构]的规定,不孕不育有多个相关的计费代码在使用。然而,与不孕不育治疗相关的费用往往高得令人望而却步,再加上缺乏普遍的保险覆盖规定,导致了医疗保健的不平等,尤其是在种族和社会经济层面。